• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Norprolac (Starter Pack)
    / Ferring Pharmaceuticals

    Active Ingredient
    Quinagolide HCl 0.025, 0.05 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    3 x 0.025 mg

    partial basket chart


    3 x 0.05 mg

    partial basket chart

    Related information


    See prescribing information for full details.


    Second line treatment of hyperprolactinemia (idiopathic or due to prolactin-secreting micro- or adenoma or macroadenoma) and its clinical manifestation (galactorrhea, oligomenorrhea, infertility, reduced libido).


    Hypersensitivity to the drug. Impaired hepatic or renal function.

    Special Precautions

    Women of child-bearing age who do not wish to conceive should be advised to practice a reliable method of contraception. Patients should be cautious when driving a vehicle or operating machinery. It is recommended to check blood pressure both lying and standing during the first days of therapy and following dosage increases. Particular caution is required in patients who have had psychotic episodes in their previous history.
    Pregnancy and lactation: Discontinue when pregnancy is confirmed.
    Breast-feeding cannot be recommended.

    Side Effects

    Nausea, vomiting, headache, dizziness and fatigue. Less frequent effects: anorexia, abdominal pain, constipation and diarrhea, insomnia, edema, flushing, nasal congestion and hypotension.

    Drug interactions

    No interactions have so far been reported. The tolerability may be reduced by alcohol.

    Ferring Pharmaceuticals